Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-08 5:31 pm Unchanged | 13G | PUMA BIOTECHNOLOGY INC PBYI | BlackRock Inc. BLK | 3,827,223 7.800% | 0 (Unchanged) | View |
| 2024-10-22 3:24 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | BlackRock Inc. BLK | 3,827,223 7.800% | 1,924,086 (+101.10%) | View |
| 2024-03-29 10:40 am Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | Frazier Life Sciences Public Fund L.P. | 2,631,713 5.400% | 2,631,713 (New Position) | View |
| 2024-02-14 08:19 am Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | Camber Capital Management LP | 2,805,000 5.900% | -1,430,000 (-33.77%) | View |
| 2024-02-13 5:12 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | VANGUARD GROUP INC | 3,802,081 7.990% | 213,159 (+5.94%) | View |
| 2024-02-06 3:54 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | ACORN BIOVENTURES L.P. | 2,934,496 6.200% | 194,561 (+7.10%) | View |
| 2024-01-30 4:08 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | MILLENNIUM MANAGEMENT LLC | 3,164,249 6.700% | 487,336 (+18.21%) | View |
| 2023-09-01 10:18 am Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | ACORN BIOVENTURES L.P. | 2,739,935 5.800% | 2,739,935 (New Position) | View |
| 2023-02-14 08:30 am Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | Camber Capital Management LP | 4,235,000 9.280% | 2,185,000 (+106.59%) | View |
| 2023-02-09 11:30 am Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | VANGUARD GROUP INC | 3,588,922 7.860% | -91,265 (-2.48%) | View |
| 2023-02-07 4:33 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | GOLDMAN SACHS GROUP INC GS | 396,136 0.900% | -1,701,511 (-81.12%) | View |
| 2023-01-19 4:19 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | MILLENNIUM MANAGEMENT LLC | 2,676,913 5.800% | 439,214 (+19.63%) | View |
| 2022-12-12 6:35 pm Purchase | 13D | PUMA BIOTECHNOLOGY INC PBYI | AUERBACH ALAN H | 10,195,990 20.500% | 848,713 (+9.08%) | View |
| 2022-07-08 4:56 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | BlackRock Inc. BLK | 1,903,137 4.200% | -1,301,100 (-40.61%) | View |
| 2022-03-14 8:24 pm Purchase | 13D | PUMA BIOTECHNOLOGY INC PBYI | AUERBACH ALAN H | 9,347,277 21.000% | 2,089,066 (+28.78%) | View |
| 2022-02-14 09:35 am Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | Camber Capital Management LP | 2,050,000 5.010% | -505,000 (-19.77%) | View |
| 2022-02-11 4:21 pm Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | Flynn James E | 0 0.000% | -3,959,741 (Position Closed) | View |
| 2022-02-10 08:32 am Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | VANGUARD GROUP INC | 3,680,187 9.000% | 283,498 (+8.35%) | View |
| 2022-02-10 06:31 am Sale | 13G | PUMA BIOTECHNOLOGY INC PBYI | STATE STREET CORP STT | 578,090 1.410% | -1,663,947 (-74.22%) | View |
| 2022-02-08 4:43 pm Purchase | 13G | PUMA BIOTECHNOLOGY INC PBYI | GOLDMAN SACHS GROUP INC GS | 2,097,647 5.100% | 2,097,647 (New Position) | View |